Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Highly Suppressive Treg as a Biomarker for Immunologically Relevant Delayed (DGF) and Slow (SGF) Graft Function After Kidney Transplantation

NCT04414111 is registered in ClinicalTrials.gov with St. Louis University as lead sponsor.

NCT NCT04414111
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04414111 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Highly Suppressive Treg as a Biomarker for Immunologically Relevant Delayed (DGF) and Slow (SGF) Graft Function After Kidney Transplantation
Lead sponsor
St. Louis University
Phase
Observational
Overall status
Active, not recruiting
Start date
December 7, 2020
Completion date
July 31, 2027
Enrollment
180 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

dgf, kidney transplant; complications